BioCryst Pharmaceuticals | Rentekostnader

Interest Expense On Debt Endring Dato
Alnylam Pharmaceuticals USD 31.34M 445K 2023-12
Gilead Sciences USD 252M 20M 2023-12
Ionis Pharmaceuticals USD 4.56M 355K 2023-12
Regeneron Pharmaceuticals USD 18.3M 500K 2023-12
Roche Holding CHF 401M 53M 2023-06
Vertex Pharmaceuticals USD 10.9M 300K 2023-09



BioCryst Pharmaceuticals Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.